CytoCore Inc. (OTCMKTS:MDIT) Sees Significant Growth in Short Interest

CytoCore Inc. (OTCMKTS:MDIT) saw a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 30 shares, a growth of ∞ from the May 14th total of 0 shares. Based on an average daily volume of 7 shares, the short-interest ratio is currently 4.3 days.

CytoCore Price Performance

CytoCore has a 52-week low of $0.00 and a 52-week high of $0.00.

CytoCore Company Profile

Medite Cancer Diagnostics, Inc operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning.